Brenton Scott
Fundador en Pulmotect, Inc. .
Fortuna: 5 M $ al 31/05/2024
Perfil
Brenton Scott has founded two companies, Bondwell Technologies, Inc. in 2017 and Pulmotect, Inc. in 2007, where he holds the title of President & Chief Operating Officer.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 13/02/2023 | 21 185 283 ( 25.41% ) | 5 M $ | 31/05/2024 |
Cargos activos de Brenton Scott
| Empresas | Cargo | Inicio |
|---|---|---|
Pulmotect, Inc.
 Pulmotect, Inc. BiotechnologyHealth Technology Pulmotect, Inc. develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections. It provides safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague). The company was founded by Brenton Scott and Magnus Hook in 2007 and is headquartered in Houston, TX. | Fundador | 01/01/2007 |
Antiguos cargos conocidos de Brenton Scott.
| Empresas | Cargo | Fin |
|---|---|---|
Bondwell Technologies, Inc.
 Bondwell Technologies, Inc. BiotechnologyHealth Technology Bondwell Technologies, Inc. engages in the development of biomaterial-based platform technology. It helps utilize the natural ability of proteins, molecular tools required for every natural process. The company was founded by Brenton Scott, David Howell, Sarah E. Bondos, and Kristin A. Howell on August 7, 2017 and is headquartered in College Station, TX. | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Pulmotect, Inc.
Pulmotect, Inc. BiotechnologyHealth Technology Pulmotect, Inc. develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections. It provides safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague). The company was founded by Brenton Scott and Magnus Hook in 2007 and is headquartered in Houston, TX. | Health Technology |
Bondwell Technologies, Inc.
Bondwell Technologies, Inc. BiotechnologyHealth Technology Bondwell Technologies, Inc. engages in the development of biomaterial-based platform technology. It helps utilize the natural ability of proteins, molecular tools required for every natural process. The company was founded by Brenton Scott, David Howell, Sarah E. Bondos, and Kristin A. Howell on August 7, 2017 and is headquartered in College Station, TX. | Health Technology |
- Bolsa de valores
- Insiders
- Brenton Scott
